Pelthos Therapeutics Inc.

PTHSAMEXHealthcare● Active

$26.62

+$1.07(+4.19%)

Market Cap$17263097

P/E Ratio—

52W High$54.29

52W Low$10.6

Avg Volume15K

Open$25.75

Beta3.20

Earnings Financials Revenue

Pelthos Therapeutics Inc. (PTHS) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

PTHS · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2026Report Date: May 14, 2026

EPS Actual

-$3.09

Est. -$3.45 · +10.4%

Revenue

$0.01B

Est. $0.01B · +4.5%

Fiscal Period

Q2 FY2026

FY ends December

Report Date

May 14, 2026

After Market Close

▲ Beat EPS▲ Beat Revenue✓ 2-Quarter EPS Beat Streak

PTHS reports quarterly as a AMEX-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 12, 2026	-$2.95	—	—	—	$0.02B	—
▲ Q2 FY2026	May 14, 2026	-$3.45	-$3.09	+10.4%	$0.01B	$0.01B	+4.5%
▲ Q1 FY2026	Mar 19, 2026	-$3.95	-$2.83	+28.4%	$0.01B	$0.01B	+3.3%
▼ Q4 FY2025	Nov 13, 2025	-$0.67	-$5.30	-691.0%	$0.01B	$0.01B	-29.1%
▼ Q3 FY2025	Aug 13, 2025	-$3.10	-$5.38	-73.5%	—	—	—

Q3 FY2026

Aug 12, 2026

EPS Actual

—

EPS Est.

-$2.95

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 14, 2026Beat

EPS Actual

-$3.09

EPS Est.

-$3.45

EPS Surpr.

+10.4%

Revenue

$0.01B

Q1 FY2026

Mar 19, 2026Beat

EPS Actual

-$2.83

EPS Est.

-$3.95

EPS Surpr.

+28.4%

Revenue

$0.01B

Q4 FY2025

Nov 13, 2025Miss

EPS Actual

-$5.30

EPS Est.

-$0.67

EPS Surpr.

-691.0%

Revenue

$0.01B

Q3 FY2025

Aug 13, 2025Miss

EPS Actual

-$5.38

EPS Est.

-$3.10

EPS Surpr.

-73.5%

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2027	$0.44	$0.55	$0.70	2
Q3 FY2027	$0.42	$0.52	$0.67	1
Q2 FY2027	$0.17	$0.21	$0.27	1
Q1 FY2027	$-0.38	$-0.29	$-0.24	2
Q4 FY2026	$-2.90	$-2.26	$-1.81	2
Q3 FY2026	$-3.13	$-2.16	$-0.82	4

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2027	$0.0B	$0.0B	$0.0B	2
Q3 FY2027	$0.0B	$0.0B	$0.0B	2
Q2 FY2027	$0.0B	$0.0B	$0.0B	2
Q1 FY2027	$0.0B	$0.0B	$0.0B	2
Q4 FY2026	$0.0B	$0.0B	$0.0B	2
Q3 FY2026	$0.0B	$0.0B	$0.0B	5

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q2 FY2026	May 14, 2026	+10.4%	$26.01	$27.69	+6.46%
▲ Q1 FY2026	Mar 19, 2026	+28.4%	$24.08	$22.97	-4.61%
▼ Q4 FY2025	Nov 13, 2025	-691.0%	$37.40	$34.68	-7.27%
▼ Q3 FY2025	Aug 13, 2025	-73.5%	$19.00	$18.18	-4.32%

Q2 FY2026+6.46%

Report Date

May 14, 2026

EPS Beat/Miss

+10.4%

Price Before

$26.01

Price After

$27.69

Q1 FY2026-4.61%

Report Date

Mar 19, 2026

EPS Beat/Miss

+28.4%

Price Before

$24.08

Price After

$22.97

Q4 FY2025-7.27%

Report Date

Nov 13, 2025

EPS Beat/Miss

-691.0%

Price Before

$37.40

Price After

$34.68

Q3 FY2025-4.32%

Report Date

Aug 13, 2025

EPS Beat/Miss

-73.5%

Price Before

$19.00

Price After

$18.18

Avg Beat Reaction+0.92%

Avg Miss Reaction-5.79%

Beat Rate2 / 4 quarters

Largest Move-7.27% (Q4 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Pelthos Therapeutics Inc. (PTHS) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-3.09 — beating the analyst consensus of $-3.45 by +10.4%. PTHS has beaten EPS estimates for 2 consecutive quarters. The next PTHS earnings date is expected around September 1, 2026.

Each quarter, investors track PTHS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PTHS revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

PTHS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

PTHS earnings · 5 questions

Pelthos Therapeutics Inc.'s next earnings report is expected around September 1, 2026. PTHS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PTHS historically reports after market close (AMC).

PTHS earnings datewhen is PTHS earningsPTHS next earnings datewhen does PTHS report earningsPTHS earnings calendar

▸ Source: FMP · Pelthos Therapeutics Inc. SEC filings · US GAAP · Pelthos Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026